ES
Enavate Sciences Portfolio holdings
AUM
$507M
1-Year Est. Return
181.76%
1 Year Est. Return
+181.76%
AUM
$328M
AUM Growth
+$151M
(+86%)
Holding
7
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZBIO
1
Zenas BioPharma
ZBIO
$1.26B
| $83.5M | 25.5% |
3,761,359
|
|
||
|
SION
2
Sionna Therapeutics
SION
$1.61B
| $72.9M | 22.25% |
2,478,030
|
|
||
3
Immunome
IMNM
$2.34B
| $55.8M | 17.05% |
4,768,583
|
|
||
|
UPB
4
Upstream Bio Inc
UPB
$525M
| $46.3M | 14.13% |
2,459,703
|
|
||
|
BBOT
5
BridgeBio Oncology
BBOT
$759M
| $30.4M | 9.29% |
+2,626,946
|
|
||
6
Compass Therapeutics
CMPX
$969M
| $27.3M | 8.32% |
7,788,150
|
|
||
7
CAMP4 Therapeutics
CAMP
$288M
| $11.4M | 3.47% |
3,785,802
|
|